
Jeffrey E. Russel
Examiner (ID: 13185, Phone: (571)272-0969 , Office: P/1675 )
| Most Active Art Unit | 1654 |
| Art Unit(s) | 1815, 1103, 1621, 1811, 1653, 1675, 2899, 1654, 1809 |
| Total Applications | 3437 |
| Issued Applications | 2371 |
| Pending Applications | 237 |
| Abandoned Applications | 837 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 575681
[patent_doc_number] => 07452528
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-11-18
[patent_title] => 'Peptide-based carbon nanotube hair colorants and their use in hair colorant and cosmetic compositions'
[patent_app_type] => utility
[patent_app_number] => 11/093873
[patent_app_country] => US
[patent_app_date] => 2005-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 9692
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/452/07452528.pdf
[firstpage_image] =>[orig_patent_app_number] => 11093873
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/093873 | Peptide-based carbon nanotube hair colorants and their use in hair colorant and cosmetic compositions | Mar 29, 2005 | Issued |
Array
(
[id] => 211213
[patent_doc_number] => 07622119
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-11-24
[patent_title] => 'Cancer antigen peptides derived from WT1'
[patent_app_type] => utility
[patent_app_number] => 10/594507
[patent_app_country] => US
[patent_app_date] => 2005-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 12462
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/622/07622119.pdf
[firstpage_image] =>[orig_patent_app_number] => 10594507
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/594507 | Cancer antigen peptides derived from WT1 | Mar 29, 2005 | Issued |
Array
(
[id] => 13790
[patent_doc_number] => 07803764
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-09-28
[patent_title] => 'Amphipathic glycopeptides'
[patent_app_type] => utility
[patent_app_number] => 10/594515
[patent_app_country] => US
[patent_app_date] => 2005-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 15807
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/803/07803764.pdf
[firstpage_image] =>[orig_patent_app_number] => 10594515
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/594515 | Amphipathic glycopeptides | Mar 24, 2005 | Issued |
Array
(
[id] => 7250102
[patent_doc_number] => 20050272652
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-08
[patent_title] => 'Peptide analogues of GIP for treatment of diabetes, insulin resistance and obesity'
[patent_app_type] => utility
[patent_app_number] => 11/090787
[patent_app_country] => US
[patent_app_date] => 2005-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 59
[patent_figures_cnt] => 59
[patent_no_of_words] => 28077
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0272/20050272652.pdf
[firstpage_image] =>[orig_patent_app_number] => 11090787
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/090787 | Peptide analogues of GIP for treatment of diabetes, insulin resistance and obesity | Mar 24, 2005 | Abandoned |
Array
(
[id] => 914510
[patent_doc_number] => 07326688
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-02-05
[patent_title] => 'Analogs of gastric inhibitory polypeptide and their use of treatment for diabetes'
[patent_app_type] => utility
[patent_app_number] => 11/090825
[patent_app_country] => US
[patent_app_date] => 2005-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 32
[patent_no_of_words] => 7248
[patent_no_of_claims] => 135
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/326/07326688.pdf
[firstpage_image] =>[orig_patent_app_number] => 11090825
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/090825 | Analogs of gastric inhibitory polypeptide and their use of treatment for diabetes | Mar 24, 2005 | Issued |
Array
(
[id] => 7005696
[patent_doc_number] => 20050171009
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-04
[patent_title] => 'Acidic insulin preparations with improved stability'
[patent_app_type] => utility
[patent_app_number] => 11/089777
[patent_app_country] => US
[patent_app_date] => 2005-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4289
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0171/20050171009.pdf
[firstpage_image] =>[orig_patent_app_number] => 11089777
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/089777 | Acidic insulin preparations having improved stability | Mar 24, 2005 | Issued |
Array
(
[id] => 560589
[patent_doc_number] => 07157554
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-01-02
[patent_title] => 'Glycopeptide carboxy-saccharide derivatives'
[patent_app_type] => utility
[patent_app_number] => 11/080130
[patent_app_country] => US
[patent_app_date] => 2005-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18801
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/157/07157554.pdf
[firstpage_image] =>[orig_patent_app_number] => 11080130
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/080130 | Glycopeptide carboxy-saccharide derivatives | Mar 14, 2005 | Issued |
Array
(
[id] => 7038816
[patent_doc_number] => 20050158250
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-21
[patent_title] => 'Composition of insulin for nasal administration'
[patent_app_type] => utility
[patent_app_number] => 11/078292
[patent_app_country] => US
[patent_app_date] => 2005-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7224
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0158/20050158250.pdf
[firstpage_image] =>[orig_patent_app_number] => 11078292
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/078292 | Composition of insulin for nasal administration | Mar 13, 2005 | Abandoned |
Array
(
[id] => 6983831
[patent_doc_number] => 20050153901
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-14
[patent_title] => 'Crystalline forms'
[patent_app_type] => utility
[patent_app_number] => 11/077210
[patent_app_country] => US
[patent_app_date] => 2005-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 10382
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0153/20050153901.pdf
[firstpage_image] =>[orig_patent_app_number] => 11077210
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/077210 | Crystalline forms | Mar 10, 2005 | Abandoned |
Array
(
[id] => 5586141
[patent_doc_number] => 20090105343
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-23
[patent_title] => 'Cancer Therapy And Medicaments Therefor'
[patent_app_type] => utility
[patent_app_number] => 10/592251
[patent_app_country] => US
[patent_app_date] => 2005-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 8203
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0105/20090105343.pdf
[firstpage_image] =>[orig_patent_app_number] => 10592251
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/592251 | Cancer Therapy And Medicaments Therefor | Mar 9, 2005 | Abandoned |
Array
(
[id] => 4451235
[patent_doc_number] => 07964559
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-06-21
[patent_title] => 'MVL, an antiviral protein from a cyanobacterium'
[patent_app_type] => utility
[patent_app_number] => 10/592422
[patent_app_country] => US
[patent_app_date] => 2005-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 15
[patent_no_of_words] => 22159
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/964/07964559.pdf
[firstpage_image] =>[orig_patent_app_number] => 10592422
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/592422 | MVL, an antiviral protein from a cyanobacterium | Mar 8, 2005 | Issued |
Array
(
[id] => 6951745
[patent_doc_number] => 20050226839
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-13
[patent_title] => 'Pepetide-based body surface reagents for personal care'
[patent_app_type] => utility
[patent_app_number] => 11/074473
[patent_app_country] => US
[patent_app_date] => 2005-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29496
[patent_no_of_claims] => 88
[patent_no_of_ind_claims] => 42
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0226/20050226839.pdf
[firstpage_image] =>[orig_patent_app_number] => 11074473
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/074473 | Pepetide-based body surface reagents for personal care | Mar 7, 2005 | Abandoned |
Array
(
[id] => 5022152
[patent_doc_number] => 20070148118
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-28
[patent_title] => 'Cosmetic composition for skin application suitable for relaxing expression wrinkles'
[patent_app_type] => utility
[patent_app_number] => 10/583816
[patent_app_country] => US
[patent_app_date] => 2005-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5260
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0148/20070148118.pdf
[firstpage_image] =>[orig_patent_app_number] => 10583816
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/583816 | Cosmetic composition for skin application suitable for relaxing expression wrinkles | Mar 7, 2005 | Issued |
Array
(
[id] => 7045087
[patent_doc_number] => 20050249682
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-10
[patent_title] => 'Long lasting waterproof sunscreen comprising metal oxide and peptide conditioner'
[patent_app_type] => utility
[patent_app_number] => 11/069858
[patent_app_country] => US
[patent_app_date] => 2005-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13310
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0249/20050249682.pdf
[firstpage_image] =>[orig_patent_app_number] => 11069858
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/069858 | Long lasting waterproof sunscreen comprising metal oxide and peptide conditioner | Feb 27, 2005 | Issued |
Array
(
[id] => 7045087
[patent_doc_number] => 20050249682
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-10
[patent_title] => 'Long lasting waterproof sunscreen comprising metal oxide and peptide conditioner'
[patent_app_type] => utility
[patent_app_number] => 11/069858
[patent_app_country] => US
[patent_app_date] => 2005-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13310
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0249/20050249682.pdf
[firstpage_image] =>[orig_patent_app_number] => 11069858
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/069858 | Long lasting waterproof sunscreen comprising metal oxide and peptide conditioner | Feb 27, 2005 | Issued |
Array
(
[id] => 5591420
[patent_doc_number] => 20060040872
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-02-23
[patent_title] => 'Calcium channel inhibitor'
[patent_app_type] => utility
[patent_app_number] => 11/058162
[patent_app_country] => US
[patent_app_date] => 2005-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 9636
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0040/20060040872.pdf
[firstpage_image] =>[orig_patent_app_number] => 11058162
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/058162 | Calcium channel inhibitor | Feb 15, 2005 | Abandoned |
Array
(
[id] => 5678334
[patent_doc_number] => 20060183690
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-17
[patent_title] => 'Anti-hypertensive dietary supplement'
[patent_app_type] => utility
[patent_app_number] => 11/056145
[patent_app_country] => US
[patent_app_date] => 2005-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 4880
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0183/20060183690.pdf
[firstpage_image] =>[orig_patent_app_number] => 11056145
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/056145 | Anti-hypertensive dietary supplement | Feb 13, 2005 | Issued |
Array
(
[id] => 6931715
[patent_doc_number] => 20050282750
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-22
[patent_title] => 'Treatment for dark adaptation'
[patent_app_type] => utility
[patent_app_number] => 11/055309
[patent_app_country] => US
[patent_app_date] => 2005-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 17135
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0282/20050282750.pdf
[firstpage_image] =>[orig_patent_app_number] => 11055309
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/055309 | Treatment for dark adaptation | Feb 9, 2005 | Issued |
Array
(
[id] => 4463699
[patent_doc_number] => 07935478
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-05-03
[patent_title] => 'Biological material and methods and solutions for preservation thereof'
[patent_app_type] => utility
[patent_app_number] => 10/588126
[patent_app_country] => US
[patent_app_date] => 2005-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 9
[patent_no_of_words] => 11515
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/935/07935478.pdf
[firstpage_image] =>[orig_patent_app_number] => 10588126
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/588126 | Biological material and methods and solutions for preservation thereof | Feb 1, 2005 | Issued |
Array
(
[id] => 5479537
[patent_doc_number] => 20090202494
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-13
[patent_title] => 'Combined use of glp-1 agonists and gastrin for regulating blood glucose levels'
[patent_app_type] => utility
[patent_app_number] => 10/587529
[patent_app_country] => US
[patent_app_date] => 2005-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 24176
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0202/20090202494.pdf
[firstpage_image] =>[orig_patent_app_number] => 10587529
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/587529 | Combined use of glp-1 agonists and gastrin for regulating blood glucose levels | Jan 27, 2005 | Abandoned |